Insider Trading July 1, 2026 05:42 PM

American Well Officer Executes Mandatory Share Sale Amid Stock Rally

Paul McNeice's automatic transaction to cover tax liabilities follows a 91% surge in AMWL shares as the company navigates revenue declines and leadership changes.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
AMWL

Paul Francis McNeice, serving as the Chief Accounting Officer at American Well Corp (NYSE: AMWL), executed a mandatory sale of 653 shares of Class A Common Stock on July 1, 2026. The transaction, valued at $6,092, was triggered by tax obligations associated with the vesting of restricted stock units rather than discretionary trading. This activity occurs as AMWL shares trade near a 52-week high of $9.96, reflecting a significant 91% price increase over the preceding six months. The sale leaves Mr. McNeice with a direct holding of 9,851 shares. Concurrently, American Well has reported a 18% year-over-year revenue decline to $54.9 million for the first quarter of 2026, though operating losses improved by 43%. Truist Securities maintains a Hold rating with a $7.50 price target, while co-founder Dr. Roy Schoenberg has transitioned to lead Amazon's healthcare division following his board resignation.

American Well Officer Executes Mandatory Share Sale Amid Stock Rally
AMWL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Paul McNeice executed an automatic "sell to cover" transaction of 653 shares to meet tax liabilities from restricted stock unit vesting, leaving him with 9,851 direct shares.
  • American Well reported a 18% year-over-year revenue decline to $54.9 million in Q1 2026, though operating losses improved by 43% as the company moves toward profitability.
  • Co-founder Dr. Roy Schoenberg resigned from the board to lead Amazon's healthcare division, while clinical data supports the efficacy of Amwell's SilverCloud behavioral health solution across university campuses.

Paul Francis McNeice, who serves as the Chief Accounting Officer at American Well Corp (NYSE: AMWL), completed a transaction involving the sale of 653 shares of the company's Class A Common Stock on July 1, 2026. The total value of this disposal was $6,092, calculated at a price of $9.33 per share. This activity takes place while the stock is trading in close proximity to its 52-week high of $9.96, a period that has seen the share price surge by 91% over the last six months.

It is critical to note that this transaction was not a discretionary decision by Mr. McNeice. Instead, it was an automatic "sell to cover" mechanism employed to satisfy tax liabilities that arose from the vesting and settlement of restricted stock units on the identical date. Following the completion of this mandatory sale, Mr. McNeice retains direct ownership of 9,851 shares of American Well Corp Class A Common Stock. Valuation analysis from InvestingPro suggests that the stock may currently be undervalued, with Fair Value estimates indicating potential upside for investors.

In the broader context of American Well Corporation's recent operational updates, the company reported its first-quarter 2026 financial results. These results highlighted a total revenue figure of $54.9 million, marking an 18% decline when compared to the previous year. Despite this contraction in revenue, the company demonstrated notable progress toward profitability, evidenced by a 43% improvement in its operating loss.

Market analysts from Truist Securities have maintained a Hold rating on American Well stock, establishing a price target of $7.50. In a significant leadership change, Dr. Roy Schoenberg, who co-founded American Well, resigned from the board of directors to accept a new employment opportunity. The company clarified that his departure was not related to any disagreements concerning the firm's operations or policies. Dr. Schoenberg has since been appointed by Amazon to lead its healthcare business, effective July 1.

Additionally, clinical data regarding American Well's digital health offerings has emerged. A study funded by the National Institute of Mental Health indicated positive outcomes for Amwell's SilverCloud digital behavioral health solution. This research was conducted across 26 U.S. colleges and universities, involving 6,205 students who were identified at clinical or high-risk levels for anxiety, depression, or eating disorders.

Risks

  • American Well faces continued revenue contraction, with Q1 2026 figures showing an 18% year-over-year decline, impacting the digital health sector's growth trajectory.
  • Leadership transitions, including the departure of co-founder Dr. Roy Schoenberg to Amazon, introduce uncertainty regarding strategic direction and operational continuity in the telehealth market.
  • Despite a 91% stock surge, the current price near a 52-week high may present valuation risks if revenue trends do not stabilize, affecting investor sentiment in the healthcare technology sector.

More from Insider Trading

MediaAlpha Director Nonko Liquidates $427K in MAX Shares Amid Rally Jul 1, 2026 CoreWeave Executive McBee Brannin Sells $5.47M in Stock Amid Market Shifts Jul 1, 2026 Westwood Holdings Director Emerita Susan Byrne Executes $53,882 Stock Sale Under Pre-Arranged Plan Jul 1, 2026 Trupanion COO John Gallagher Executes Pre-Arranged Stock Sale Amid Valuation Debate Jul 1, 2026 Contineum Therapeutics CEO Executes Stock Transactions Under 10b5-1 Plan Jul 1, 2026